Changes of miR‑155 expression in serum of uremic patients before and after treatment and risk factors analysis

  • Authors:
    • Hao Li
    • Fangxin Qiu
    • Fang Tian
    • Xinzheng Shi
    • Aiqin Gao
    • Lei Song
    • Junliang Liu
  • View Affiliations

  • Published online on: July 28, 2020     https://doi.org/10.3892/etm.2020.9067
  • Pages: 3352-3360
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the changes of miR‑155 expression in the serum of uremic patients before and after treatment and analyze the risk factors of efficacy. A total of 116 uremic patients admitted to the People's Hospital of Chengyang (Qingdao, China) were enrolled in the study as the uremia group, and were treated by hemodialysis combined with hemoperfusion, and 127 healthy subjects who underwent health examination during the same period were selected as the normal group. Reverse transcription quantitative PCR was used to detect the serum miR‑155 levels of all the subjects in the two groups before treatment and those of uremia patients after treatment. The changes of clinically related indicators and inflammatory factors in uremic patients before and after treatment and their correlation with miR‑155 were investigated. The risk factors affecting the efficacy of treatment were analyzed. Serum miR‑155 levels in the uremia group were higher than those in the normal group (P<0.001); the miR‑155 level in patients after treatment was significantly lower than that before treatment (P<0.001), and it was positively correlated with efficacy (r=0.6873, P<0.05). The serum miR‑155 level in the invalid group was higher than that in the effective group, and the sensitivity and specificity of miR‑155 for predicting the efficacy before treatment were 64.71 and 87.88%, respectively. After treatment, the sensitivity and specificity of miR‑155 for evaluating the efficacy were 76.47 and 88.89%, respectively. Clinically related indicators and inflammatory factor levels in uremic patients decreased significantly after treatment, and the expression levels before and after treatment were significantly correlated with miR‑155. Clinically related indicators, inflammatory factors and miR‑155 were all risk factors affecting efficacy. The expression level of miR‑155 in serum was significantly upregulated. Findings of this study suggest that monitoring miR‑155 may reflect the efficacy and inflammatory state effectively.
View Figures
View References

Related Articles

Journal Cover

October-2020
Volume 20 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li H, Qiu F, Tian F, Shi X, Gao A, Song L and Liu J: Changes of miR‑155 expression in serum of uremic patients before and after treatment and risk factors analysis. Exp Ther Med 20: 3352-3360, 2020
APA
Li, H., Qiu, F., Tian, F., Shi, X., Gao, A., Song, L., & Liu, J. (2020). Changes of miR‑155 expression in serum of uremic patients before and after treatment and risk factors analysis. Experimental and Therapeutic Medicine, 20, 3352-3360. https://doi.org/10.3892/etm.2020.9067
MLA
Li, H., Qiu, F., Tian, F., Shi, X., Gao, A., Song, L., Liu, J."Changes of miR‑155 expression in serum of uremic patients before and after treatment and risk factors analysis". Experimental and Therapeutic Medicine 20.4 (2020): 3352-3360.
Chicago
Li, H., Qiu, F., Tian, F., Shi, X., Gao, A., Song, L., Liu, J."Changes of miR‑155 expression in serum of uremic patients before and after treatment and risk factors analysis". Experimental and Therapeutic Medicine 20, no. 4 (2020): 3352-3360. https://doi.org/10.3892/etm.2020.9067